Display options
Share it on
Full text links
Silverchair Information Systems

JAMA. 1985 Dec 13;254(22):3187-9.

Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine.

JAMA

D J Weber, W A Rutala, G P Samsa, J E Santimaw, S M Lemon

PMID: 2933532

Abstract

Factors associated with lack of antibody response to the hepatitis B virus plasma vaccine were retrospectively evaluated by means of a logistic regression in 194 previously seronegative staff members of a community hospital. All subjects had received three doses of vaccine by intramuscular buttock injection using a 1-in, 23-gauge needle. Overall, only 55.7% of subjects developed detectable antibody to hepatitis B surface antigen in serum after immunization. The weight-height index served as a surrogate measure of obesity. Predictors of poor immunogenic response to hepatitis B vaccine included higher weight-height index, older age, and vaccine batch. Sex, race, timing of vaccine doses, and timing of postimmunization determination of antibody to hepatitis B surface antigen were not predictors of vaccine efficacy.

Similar articles

Cited by

Pellini R, Venuti A, Pimpinelli F, Abril E, Blandino G, Campo F, Conti L, De Virgilio A, De Marco F, Di Domenico EG, Di Bella O, Di Martino S, Ensoli F, Giannarelli D, Mandoj C, Manciocco V, Marchesi P, Mazzola F, Moretto S, Petruzzi G, Petrone F, Pichi B, Pontone M, Zocchi J, Vidiri A, Vujovic B, Piaggio G, Morrone A, Ciliberto G.
Vaccines (Basel). 2021 Jun 22;9(7). doi: 10.3390/vaccines9070685.
PMID: 34206312

Substances

MeSH terms

Publication Types

LinkOut - more resources